Good news from Norvatis on vaccines development for developing countries. I wonder which percentage of the developing countries scientists will be involved in this project? I wonder which percentage of the younger scientists of the developing countries will be involved in this project? The role of scientists from the endemic nations cannot be over-emphasized. Norvatis may need to attract sharp young scientists for short visits to their research base. In this way, the capacities needed for sustainability will be built. Thank you.